RLMD
Relmada Therapeutics Inc
3.70$
-1.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +492.3% | +55.6% | -96.9% | +85.4% | -23.0% | -66.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | -21.2% | -79.2% | +127.6% | +167.0% | +357.7% | +151.9% | +25.0% | -51.6% | -15.7% | -98.4% | |
| – | +0.0% | +8.5% | -40.8% | -32.9% | +82.4% | +243.0% | +41.1% | +36.6% | +2.0% | -22.9% | -99.2% | |
| – | 0.0% | -5.2% | -55.5% | -4.2% | +118.4% | +302.7% | +106.6% | +28.3% | -35.7% | -19.1% | -29.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | +242,990.9% | – | – | -96.5% | +8,603.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -454.0% | – | – | +124.3% | -130.1% | – | -5,603.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -1,728.9% | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.